These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10583926)

  • 1. An overview of genetic factors influencing plasma lipid levels and coronary artery disease risk.
    Ozturk IC; Killeen AA
    Arch Pathol Lab Med; 1999 Dec; 123(12):1219-22. PubMed ID: 10583926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids.
    Iglesias A; Arranz M; Alvarez JJ; Perales J; Villar J; Herrera E; Lasunción MA
    Clin Chim Acta; 1996 Apr; 248(2):157-74. PubMed ID: 8740580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid and apolipoprotein concentrations in prenodal leg lymph of fasted humans. Associations with plasma concentrations in normal subjects, lipoprotein lipase deficiency, and LCAT deficiency.
    Nanjee MN; Cooke CJ; Olszewski WL; Miller NE
    J Lipid Res; 2000 Aug; 41(8):1317-27. PubMed ID: 10946020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein.
    Riemens S; van Tol A; Sluiter W; Dullaart R
    Atherosclerosis; 1998 Sep; 140(1):71-9. PubMed ID: 9733217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid and apolipoprotein levels and distribution in patients with hypertriglyceridemia: effect of triglyceride reductions with atorvastatin.
    Le NA; Innis-Whitehouse W; Li X; Bakker-Arkema R; Black D; Brown WV
    Metabolism; 2000 Feb; 49(2):167-77. PubMed ID: 10690940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of insulin sensitivity and the TaqIB cholesteryl ester transfer protein gene polymorphism on plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities and their response to hyperinsulinemia in non-diabetic men.
    Riemens SC; Van Tol A; Stulp BK; Dullaart RP
    J Lipid Res; 1999 Aug; 40(8):1467-74. PubMed ID: 10428983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein B and apolipoprotein AI as predictors of coronary artery disease.
    Sniderman AD
    Can J Cardiol; 1988 Jul; 4 Suppl A():24A-30A. PubMed ID: 3141025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interrelationships between postprandial lipoprotein B:CIII particle changes and high-density lipoprotein subpopulation profiles in mixed hyperlipoproteinemia.
    Saïdi Y; Sich D; Camproux A; Egloff M; Federspiel MC; Gautier V; Raisonnier A; Turpin G; Beucler I
    Metabolism; 1999 Jan; 48(1):60-7. PubMed ID: 9920146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-density lipoprotein: relations to metabolic parameters and severity of coronary artery disease.
    Tornvall P; Karpe F; Proudler A; Båvenholm P; Landou C; Olivecrona T; Hamsten A
    Metabolism; 1996 Nov; 45(11):1375-82. PubMed ID: 8931642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of lipid transfer proteins on lipoprotein lipase induced transformation of VLDL and HDL.
    Murdoch SJ; Breckenridge WC
    Biochim Biophys Acta; 1996 Oct; 1303(3):222-32. PubMed ID: 8908157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia.
    Tall A; Sammett D; Granot E
    J Clin Invest; 1986 Apr; 77(4):1163-72. PubMed ID: 3958185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Action of atorvastatin in combined hyperlipidemia : preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles.
    Guerin M; Lassel TS; Le Goff W; Farnier M; Chapman MJ
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):189-97. PubMed ID: 10634817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Families with familial combined hyperlipidemia and families enriched for coronary artery disease share genetic determinants for the atherogenic lipoprotein phenotype.
    Allayee H; Aouizerat BE; Cantor RM; Dallinga-Thie GM; Krauss RM; Lanning CD; Rotter JI; Lusis AJ; de Bruin TW
    Am J Hum Genet; 1998 Aug; 63(2):577-85. PubMed ID: 9683614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal study on lipoprotein profile, high density lipoprotein subclass, and postheparin lipases during gestation in women.
    Alvarez JJ; Montelongo A; Iglesias A; Lasunción MA; Herrera E
    J Lipid Res; 1996 Feb; 37(2):299-308. PubMed ID: 9026528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of cholesteryl ester transfer in plasma by hormone-replacement therapy.
    Ritsch A; Kaser S; Volgger B; Abfalter E; Sturm W; Gänzer H; Föger B; Kirchmair R; Ebenbichler C; Patsch JR
    Metabolism; 2002 May; 51(5):599-604. PubMed ID: 11979392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum apolipoprotein A1, B, CII, CIII, E, and lipoprotein (a) levels in children.
    Baroni S; Scribano D; Valentini P; Zuppi C; Ranno O; Giardina B
    Clin Biochem; 1996 Dec; 29(6):603-5. PubMed ID: 8939411
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
    Murdoch SJ; Breckenridge WC
    Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hormone replacement therapy and hepatic lipase polymorphism on serum lipid profiles in postmenopausal Japanese women.
    Somekawa Y; Umeki H; Kobayashi K; Tomura S; Aso T; Hamaguchi H
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4766-70. PubMed ID: 12364471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia.
    Cheung MC; Austin MA; Moulin P; Wolf AC; Cryer D; Knopp RH
    Atherosclerosis; 1993 Aug; 102(1):107-19. PubMed ID: 8257447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.